EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pre-Transplant Immune Dysregulation Predicts for Poor Outcome Following Allogeneic Haematopoietic Stem Cell Transplantation in Adolescents and Adults with Inborn Errors of Immunity (IEI)

Thomas A Fox, Valerie Massey, Charley Lever, Rachel Pearce, Arian Laurence, Sarah Grace, Filippo Oliviero, Sarita Workman, Andrew Symes, David M Lowe, Valeria Fiaccadori, Rachael Hough und 5 weitere

Journal of Clinical Immunology · 2025-12 · 45 (1)

DOI: 10.1007/s10875-024-01854-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Immunology, online erschienen am 06.01.2025. Verfasst von Thomas A Fox und 16 weiteren Autor:innen. Beteiligte Einrichtung: UCL Institute of Immunity and Transplantation, UCL, London, UK. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Graft vs Host Disease, Transplantation, Homologous. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Allogeneic haematopoietic stem cell transplantation (alloHSCT) is safe and effective for adolescents and adults with inborn errors of immunity (IEI) with severe manifestations of their disease. The haematopoietic cell transplantation comorbidity index (HCT-CI) score predicts transplant survival in non-malignant diseases, including IEIs. We hypothesised that immune dysregulation pre-transplant may also influence transplant outcomes. We calculated the pre-transplant immune dysregulation and disease activity score (IDDA v2.1) for 82 adolescent and adult IEI patients (aged ≥ 13 years). Three-year overall survival (OS) for the whole cohort was 90% ( n = 82) with a median follow up of 44.7 months (range 8.4 to 225.8). Events were defined as acute graft-versus-host disease (GvHD) grades II or above, chronic GvHD of any grade, graft failure, or death from any cause. Three-year event free survival (EFS) for the whole cohort was 72%. In multivariable analysis the IDDA v2.1 score pre-transplant and HCT-CI score significantly impacted OS (hazard ratio 1.08, p = 0.028) and EFS (hazard ratio 1.04, p = 0.0005). Importantly, 35% of this cohort had a high IDDA v2.1 score (≥ 15) and low HCT-CI score (< 3) suggesting that the risks of alloHSCT may be underestimated in a proportion of patients with IEI if the HCT-CI score is used alone. These findings support the potential for improved outcomes following successful modulation of immune dysregulation pre-transplant. The IDDA v2.1 score has utility as an objective measurement of pre-transplant immune dysregulation providing additional information regarding the risks and potential complications of alloHSCT in an individual IEI patient.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationGraft vs Host DiseaseTransplantation, HomologousHumansAdolescentFemaleAdultMaleYoung AdultTreatment OutcomePrognosisMiddle AgedImmune System Diseases

Stichwörter der Autor:innen

Inborn errors of immunityStem cell transplantation

Autor:innen und Institutionen

  • UCL Institute of Immunity and Transplantation, UCL, London, UK.
  • Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Department of Immunology, Royal Free London Hospitals NHS Foundation Trust, London, UK.
  • Kings College London, London, UK.
  • Division of Pediatric Hematology-Oncology, Department of Pediatrics and Adolescent Medicine, Styrian Children's Cancer Research Unit for Cancer and Inborn Errors of the Blood and Immunity in Children, Medical University…
  • UCL Institute of Immunity and Transplantation, UCL, London, UK. e.morris@ucl.ac.uk.

Zitieren

APA

Fox, T. A., Massey, V., Lever, C., Pearce, R., Laurence, A., Grace, S., Oliviero, F., Workman, S., Symes, A., Lowe, D. M., Fiaccadori, V., Hough, R., Tadros, S., Burns, S. O., Seidel, M. G., Carpenter, B., & Morris, E. C. (2025). Pre-Transplant Immune Dysregulation Predicts for Poor Outcome Following Allogeneic Haematopoietic Stem Cell Transplantation in Adolescents and Adults with Inborn Errors of Immunity (IEI). Journal of Clinical Immunology, 45(1). https://doi.org/10.1007/s10875-024-01854-y

Vancouver

Fox TA, Massey V, Lever C, Pearce R, Laurence A, Grace S, et al. Pre-Transplant Immune Dysregulation Predicts for Poor Outcome Following Allogeneic Haematopoietic Stem Cell Transplantation in Adolescents and Adults with Inborn Errors of Immunity (IEI). Journal of Clinical Immunology. 2025;45(1). doi:10.1007/s10875-024-01854-y

BibTeX
@article{Fox2025,
  author = {Fox, Thomas A and Massey, Valerie and Lever, Charley and Pearce, Rachel and Laurence, Arian and Grace, Sarah and Oliviero, Filippo and Workman, Sarita and Symes, Andrew and Lowe, David M and Fiaccadori, Valeria and Hough, Rachael and Tadros, Susan and Burns, Siobhan O and Seidel, Markus G and Carpenter, Ben and Morris, Emma C},
  title = {Pre-Transplant Immune Dysregulation Predicts for Poor Outcome Following Allogeneic Haematopoietic Stem Cell Transplantation in Adolescents and Adults with Inborn Errors of Immunity (IEI)},
  journal = {Journal of Clinical Immunology},
  year = {2025},
  volume = {45},
  number = {1},
  doi = {10.1007/s10875-024-01854-y}
}
Kostenlos starten →